NIH-funded research R21 grant

Creating DNA structures to block COVID-19 virus infection

Official title: Programming designer DNA nanostructures for blocking enveloped viral infection

Funded at Louisiana State Univ A&m Col Baton Rouge · NIH-10888153 · Data updated 2026-11-12

This study is exploring a new way to create tiny DNA structures that can trap and stop the COVID-19 virus from infecting people, aiming to develop safe and affordable treatments for everyone.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionLouisiana State Univ A&m Col Baton Rouge
NIH-funded
Lab location1 site (Baton Rouge, United States)
Project startJuly 14, 2023
Project endJune 30, 2025
Funding year2024
Award (this year)$228,149
NIH project number5R21AI166898-02
Project IDNIH-10888153 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at high risk for COVID-19 infection, including those with underlying health conditions or exposure to the virus.

Less likely to help

Patients who are not at risk for COVID-19 or those who have already been vaccinated may not receive direct benefits from this research.

What this research studies

This research focuses on developing innovative DNA nanostructures designed to block the infection of SARS-CoV-2, the virus responsible for COVID-19. By utilizing the unique structure of the virus's spike proteins, the researchers aim to create a macromolecular 'net' that can capture and neutralize the virus effectively. The approach involves engineering DNA to match the precise layout of the spike proteins, enhancing the ability to bind and prevent the virus from infecting cells. This could lead to affordable and biocompatible antiviral treatments.

Why it matters

Potential benefit: If successful, this research could provide a new method for preventing COVID-19 infections, potentially leading to better control of the pandemic.

How similar studies have gone: While the approach of using DNA nanostructures is innovative, similar strategies in targeting viral infections have shown promise in preliminary studies.

Where this research is happening

  • Louisiana State Univ A&m Col Baton Rouge
    Baton Rouge, United States
    Active

Researchers

  • Principal investigator: Huang, Weishan — Louisiana State Univ A&m Col Baton Rouge
  • Study coordinator: Huang, Weishan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.